SPECIALTY INJECTABLE MARKET ANALYSIS

Key Takeaways from Analyst

Specialty injectable industry can witness robust growth due to rising prevalence of chronic diseases. As population continue to age globally, conditions like cancer, diabetes and autoimmune disorders requiring complex drug therapies will boost demand for injectable.

Biosimilars may pose a threat to branded drugs by losing patent protection. Regulatory delays in biosimilar approvals and lack of interchangeability continue limiting biosimilar uptake.

North America currently dominates the market, owing to the concentration of major pharmaceutical players and availability of advanced healthcare facilities. However, Asia Pacific is expected to emerge as the fastest growing regional market with nations like China and India improving access to healthcare.